Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia

Thumbnail Image

Files

McCubreyTripleAktInhibitionasaNewTherapeuticStrategy.pdf (4.64 MB)

Date

2015-03-02

Authors

McCubrey, James A.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

T-acute lymphoblastic leukemia, Perifosine, small molecules inhibitors (SMI)

Citation

URI

http://hdl.handle.net/10342/9587

DOI

10.18632/oncotarget.3260

Collections

Microbiology and Immunology

Endorsement

Review

Supplemented By

Referenced By